1-15 of 15
James F Holland
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Predictors Of Response To Rigosertib In Patients With a Myelodysplastic Syndrome (MDS) Or Acute Myeloid Leukemia (AML) Relapsing After Or Refractory To Hypomethylating Agents

Shyamala C. Navada, MD, Rosalie Odchimar-Reissig, RN, E. Premkumar Reddy, PhD, Erin P Demakos, RN, CCRN, James F Holland, MD, Francois Wilhelm, MD, PhD., Lewis R. Silverman, MD
Journal: Blood
Blood (2013) 122 (21): 1527.
https://doi.org/10.1182/blood.V122.21.1527.1527
Published: 2013
Journal Articles

Dose Escalation of Azacitidine in Patients Failing Standard or Investigational Combinations of the Agent in the Myelodysplastiic Syndrome or Evolved AML

Lewis R. Silverman, MD, Shyamala C. Navada, MD, Rosalie Odchimar-Reissig, RN, Maria Michalak, PA-C, Erin P Demakos, RN, CCRN, James F Holland, MD
Journal: Blood
Blood (2012) 120 (21): 4932.
https://doi.org/10.1182/blood.V120.21.4932.4932
Published: 2012
Journal Articles

Evaluation of Rigosertib in Patients with a Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Relapsed or Refractory to Hypomethylating Agents: A Phase I/II Study

Shyamala C. Navada, MD, Rosalie Odchimar-Reissig, RN, E. Premkumar Reddy, PhD, James F Holland, MD, Francois Wilhelm, MD, PhD., Lewis R. Silverman, MD
Journal: Blood
Blood (2012) 120 (21): 3794.
https://doi.org/10.1182/blood.V120.21.3794.3794
Published: 2012
Journal Articles

Evaluation of ON01910.Na In Patients with a Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Relapsed or Refractory to Hypomethylating Agents: A Phase I Study

Lewis R Silverman, MD, Shyamala C. Navada, MD, Rosalie Odchimar-Reissig, RN, Vesna Najfeld, PhD, Takao Ohnuma, MD, Francois Wilhelm, MD, PhD., E. Premkumar Reddy, Ph.D., James F. Holland, MD
Journal: Blood
Blood (2010) 116 (21): 2944.
https://doi.org/10.1182/blood.V116.21.2944.2944
Published: 2010
Journal Articles

Effects of a Novel Benzyl Styryl Sulfone Derivative ON 01910.Na On the Myelodysplastic Syndrome (MDS) Derived Clone in Patients Relapsing Following Response to Azacitidine (AzaC) Therapy.

Lewis R. Silverman, MD, Rosalie Odchimar-Reissig, Shyamala C. Navada, MD, Takao Ohnuma, MD, Vesna Najfeld, Ph.D., Francois Wilhelm, MD, Ph.D, E. Premkumar Reddy, PhD, James F Holland
Journal: Blood
Blood (2009) 114 (22): 4839.
https://doi.org/10.1182/blood.V114.22.4839.4839
Published: 2009
Journal Articles

Analysis of Survival, AML Transformation, and Transfusion Independence in Patients with High-Risk Myelodysplastic Syndromes (MDS) Receiving Azacitidine Determined Using a Prognostic Model.

Lewis R. Silverman, MD, David R. McKenzie, MS, Bercedis L. Peterson, PhD, Erin P. Demakos, RN, CCRC, James F. Holland, MD, Richard R. Larson, MD, The Cancer Leukemia Group B (CALGB).
Journal: Blood
Blood (2005) 106 (11): 2523.
https://doi.org/10.1182/blood.V106.11.2523.2523
Published: 2005
Journal Articles

Azacitidine Prolongs Survival and Time to AML Transformation in High-Risk Myelodysplastic Syndrome (MDS) Patients ≥ 65 Years of Age.

Lewis R. Silverman, MD, David R. McKenzie, MS, Bercedis L. Peterson, PhD, Erin P. Demakos, RN, CCRC, Neil T. Malone, MA, James F. Holland, MD, Richard A. Larson, MD, The Cancer Leukemia Group B (CALGB).
Journal: Blood
Blood (2005) 106 (11): 2524.
https://doi.org/10.1182/blood.V106.11.2524.2524
Published: 2005
Journal Articles

Quantitative Studies of Localized Leukocyte Mobilization in Acute Leukemia

JAMES F. HOLLAND, M.D., HANSJOERG SENN, M.D., TARIT BANERJEE, M.D.
Journal: Blood
Blood (1971) 37 (5): 499–511.
https://doi.org/10.1182/blood.V37.5.499.499
Published: 1971
Journal Articles

Arabinosyl Cytosine: A Useful Agent in the Treatment of Acute Leukemia in Adults

ROSE RUTH ELLISON, JAMES F. HOLLAND, CA 02599, MARISE WEIL, CLAUDE JACQUILLAT, MICHEL BOIRON, JEAN BERNARD, ARTHUR SAWITSKY, CA 05923, FRED ROSNER, CA 05923, BERNARD GUSSOFF, CA 05923, RICHARD T. SILVER, CA 07968, ARTHUR KARANAS, CA 07968, JANET CUTTNER, CA 04457, CHARLES L. SPURR, CA 03927, DONALD M. HAYES, CA 03927, JOHANNES BLOM, LOUIS A. LEONE, CA 08025, FARID HAURANI, CA 05462, ROBERT KYLE, CA 04646, J. L. HUTCHINSON, R. JACKSON FORCIER, CA 04326, JOHN H. MOON, CA 03735
Journal: Blood
Blood (1968) 32 (4): 507–523.
https://doi.org/10.1182/blood.V32.4.507.507
Published: 1968
Journal Articles

Melphalan in Multiple Myeloma

BARTH HOOGSTRATEN, PAUL R. SHEEHE, JANET CUTTNER, TALBERT COOPER, ROBERT A. KYLE, RICHARD A. OBERFIELD, STUART R. TOWNSEND, JOHN B. HARLEY, DONALD M. HAYES, GIOVANNI COSTA, JAMES F. HOLLAND
Journal: Blood
Blood (1967) 30 (1): 74–83.
https://doi.org/10.1182/blood.V30.1.74.74
Published: 1967
Journal Articles

A Controlled Trial of Urethane Treatment in Multiple Myeloma

JAMES F. HOLLAND, M.D., HENRY HOSLEY, M.D., CAROL SCHARLAU, PAUL P. CARBONE, M.D., EMIL FREI, III, M.D., CLYDE O. BRINDLEY, M.D., THOMAS C. HALL, M.D., BRUCE I. SHNIDER, M.D., G. LENNARD GOLD, M.D., LOUIS LASAGNA, M.D., ALBERT H. OWENS, JR., M.D., SHERWOOD P. MILLER, M.D.
Journal: Blood
Blood (1966) 27 (3): 328–342.
https://doi.org/10.1182/blood.V27.3.328.328
Published: 1966
Journal Articles

The Effectiveness of Combinations of Antileukemic Agents in Inducing and Maintaining Remission in Children with Acute Leukemia

EMIL FREI, III, MYRON KARON, ROBERT H. LEVIN, EMIL J. FREIREICH, ROBERT J. TAYLOR, JULIET HANANIAN, OLEG SELAWRY, JAMES F. HOLLAND, BARTH HOOGSTRATEN, IRVING J. WOLMAN, ESSHAGH ABIR, ARTHUR SAWITSKY, STANLEY LEE, STEPHAN D. MILLS, E. OMER BURGERT, JR., CHARLES L. SPURR, RICHARD B. PATTERSON, FRANKLIN G. EBAUGH, G. WATSON JAMES, III, JOHN H. MOON
Journal: Blood
Blood (1965) 26 (5): 642–656.
https://doi.org/10.1182/blood.V26.5.642.642
Published: 1965
Journal Articles

Studies of Sequential and Combination Antimetabolite Therapy in Acute Leukemia: 6-Mercaptopurine and Methotrexate

Emil Frei, III, M.D., Emil J. Freireich, M.D., Edmund Gehan, Ph.D., Donald Pinkel, M.D., James F. Holland, M.D., Oleg Selawry, M.D., Farid Haurani, M.D., Charles L. Spurr, M.D., Donald M. Hayes, M.D., G. Watson James, M.D., Harvey Rothberg, M.D., D. Bruce Sodee, M.D., R. Wayne Rundles, M.D., Leslie R. Schroeder, M.D., Barth Hoogstraten, M.D., Irving J. Wolman, M.D., D. G. Traggis, M.D., Talbert Cooper, M.D., B. R. Gendel, M.D., Franklin Ebaugh, M.D., Robert Taylor, M.A.
Journal: Blood
Blood (1961) 18 (4): 431–454.
https://doi.org/10.1182/blood.V18.4.431.431
Published: 1961
Journal Articles

Evaluation of a New Chemotherapeutic Agent in Patients with "Advanced Refractory" Acute Leukemia. Studies of 6-Azauracil

EMIL J. FREIREICH, EMIL FREI, III, JAMES F. HOLLAND, DONALD PINKEL, OLEG SELAWRY, HARVEY ROTHBERG, FARID HAURANI, ROBERT TAYLOR, EDMUND A. GEHAN
Journal: Blood
Blood (1960) 16 (3): 1268–1278.
https://doi.org/10.1182/blood.V16.3.1268.1268
Published: 1960
Journal Articles

A Comparative Study of Two Regimens of Combination Chemotherapy in Acute Leukemia

EMIL FREI, III, JAMES F. HOLLAND, MARVIN A. SCHNEIDERMAN, DONALD PINKEL, GEORGE SELKIRK, EMIL J. FREIREICH, RICHARD T. SILVER, G. LENNARD GOLD, WILLIAM REGELSON
Journal: Blood
Blood (1958) 13 (12): 1126–1148.
https://doi.org/10.1182/blood.V13.12.1126.1126
Published: 1958